Literature DB >> 18089686

Clinical and immunological manifestations in 151 SLE patients living in Dubai.

J AlSaleh1, V Jassim, M ElSayed, N Saleh, D Harb.   

Abstract

To gain better understanding of systemic lupus erythematosus (SLE) in Dubai we studied the clinical and immunological manifestations in a cohort of 151 patients attended Rheumatology Clinic in Dubai Hospital between January 2002 and January 2007. We found that the female to male ratio was 20.5:1, with a mean age of 35.5 years (0.9). The mean age at disease onset was 28.9 years (0.8) and mean disease duration 6.7 years (0.4). Five-year survival rate in our cohort was 94%. The commonest clinical manifestations in this cohort were arthritis (88%), haematological abnormalities (61.6%), and malar rash (60.3%). Leucopenia, fever, hair loss and proteinuria were observed in approximately half of the patients. Anaemia was found in 44.3% but only 9.9% had haemolytic anaemia. Photosensitive rash was seen in 43% of patients. Approximately one-third of the patients had serositis and mouth ulcers, 30.5 and 27.2% respectively. Vasculitis was observed in 19.2% of patients. Neuropsychiatric manifestations (15.9%), discoid lupus lesions (12.6%), and brain infarcts (13.2%) were infrequent. Subacute cutaneous lupus (6%) was also uncommon. Anti-nuclear antibodies were detected in 98%, anti-double stranded DNA antibodies in 88.7%, anti-Sm antibodies in 19.7%, anti-RNP in 40.4%, anti-Ro antibodies in 52.3% and anti-La antibodies in 19.8%. Anti-cardiolipin IgM and IgG were detected in 25.3 and 22.4%, respectively. This study suggests that Arabs with SLE residing in Dubai have comparable clinical features to their counterparts in other Arab countries and Western countries. The high prevalence of positive anti-Ro antibodies among our Arab patients probably reflects a character, that is, commonly seen in SLE patients of Middle East origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18089686     DOI: 10.1177/0961203307084297

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program.

Authors:  Michelle Housey; Peter DeGuire; Sarah Lyon-Callo; Lu Wang; Wendy Marder; W Joseph McCune; Charles G Helmick; Caroline Gordon; J Patricia Dhar; James Leisen; Emily C Somers
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

2.  Systemic Lupus Erythematosus in India: A Clinico-Serological Correlation.

Authors:  Rachita Mathur; Kirti Deo; Aishwarya Raheja
Journal:  Cureus       Date:  2022-06-08

3.  Clinical and laboratory manifestations of yemeni patients with systemic lupus erythematosus.

Authors:  Hassan A Al-Shamahy; Najla H M Dhaifallah; Yahya M Al-Ezzy
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

4.  Neuropsychiatric lupus.

Authors:  Amal Alkhotani
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

5.  Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients.

Authors:  Marwan Adwan
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

6.  Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity.

Authors:  Rasha T Hamza; Khaled S Awwad; Mohamed K Ali; Amira I Hamed
Journal:  Med Sci Monit       Date:  2011-12

7.  Pulmonary manifestations in systemic lupus erythematosus: association with disease activity.

Authors:  Omer S B Alamoudi; Suzan M Attar
Journal:  Respirology       Date:  2015-01-30       Impact factor: 6.424

8.  High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.

Authors:  Ali A Al-Jabri; Amal K Al-Gahdani; Ibtisam Al-Shuaili
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 3.580

9.  Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital.

Authors:  Paul Etau Ekwom
Journal:  Clin Rheumatol       Date:  2013-03-03       Impact factor: 3.650

10.  Associates and predictors of pleurisy or pericarditis in SLE.

Authors:  Seungwon Ryu; Wei Fu; Michelle A Petri
Journal:  Lupus Sci Med       Date:  2017-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.